Indeed, neither homozygous deletion/mutation of p107 and p130 nor mutation/copy number variations of upstream factors like p16INK4A, CDK4 or Cyclin D – which are common features of many tumor types [52] – have been described. This evidence concerns the gene RBL1 and neoplasm.